Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TACR1 | P25103 | 10/20 | 0.60 |
| ▸ | KCNH2 | Q12809 | 3/20 | 0.47 |
| ▸ | S1PR5 | Q9H228 | 2/20 | 0.44 |
| ▸ | ABCB1 | P08183 | 2/20 | 0.43 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.43 |
| ▸ | FFAR4 | Q5NUL3 | 1/20 | 0.42 |
| ▸ | SLC1A5 | Q15758 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7699901 | 0.99 | TACR1 (0.59) | TACR1KCNH2S1PR5ABCB1SIGMAR1 | |
| SCHEMBL7699833 | 0.90 | TACR1 (0.49) | TACR1KCNH2ABCB1SIGMAR1SLC1A5 | |
| SCHEMBL7707683 | 0.89 | TACR1 (0.55) | TACR1KCNH2SLC1A5 | |
| SCHEMBL7702105 | 0.88 | TACR1 (0.47) | TACR1KCNH2ABCB1SIGMAR1 | |
| SCHEMBL7699781 | 0.87 | TACR1 (0.61) | TACR1KCNH2ABCB1 | |
| SCHEMBL7705823 | 0.85 | TACR1 (0.44) | TACR1KCNH2ABCB1SIGMAR1 | |
| SCHEMBL7705623 | 0.85 | TACR1 (0.56) | TACR1KCNH2SLC1A5 | |
| SCHEMBL7699913 | 0.84 | TACR1 (0.42) | TACR1KCNH2ABCB1SIGMAR1 | |
| SCHEMBL7705827 | 0.82 | TACR1 (0.56) | TACR1KCNH2ABCB1SIGMAR1 | |
| SCHEMBL7704919 | 0.82 | TACR1 (0.54) | TACR1SIGMAR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1242399-A1 | $g(a)-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS | UCB S.A. (BE) | 2002-09-25 | — | — | EP | claimed |
| WO-2001046167-A1 | α-ARYLETHYLPIPERAZINE DERIVATIVES AS NEUROKININ ANTAGONISTS | UCB, S.A. (BE) | 2001-06-28 | — | — | WO | claimed |